Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography

Abdom Imaging. 2007 Nov;32(6):730-6. doi: 10.1007/s00261-006-9173-1. Epub 2007 Feb 7.

Abstract

Background: Objective of the present study was to assess activity or vascularization of focal liver lesions in alveolar echinococcosis (AE) using [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) in comparison with contrast enhanced ultrasound (CEUS) and three-phase helical computed tomography (CT).

Methods: In this prospective study, 17 patients with confirmed AE of the liver were included (6 males, 11 females; average age: 59 +/- 16 years; average duration of disease: 10.5 years) and were then examined using FDG-PET, precontrast ultrasound (US), CEUS, and three-phase helical CT. We assessed metabolic activity (FDG-PET) and vascularization (CEUS and CT) of Echinococcus multilocularis specific hepatic lesions.

Results: FDG-PET identified increased metabolic activity in the corresponding lesions in seven patients (41.2%). A vascularization pattern of echinococcal lesions was visualized in 9 patients (52.9%) by CEUS and in 4 patients (23.5%) by CT. All positive FDG-PET findings were also positive at CEUS.

Conclusions: There was association between findings of metabolic activity in AE at FDG-PET and vascularized lesions of the liver returned by CEUS. This suggests that CEUS may represent a cost-effective tool in the decision making to perform FDG-PET examination.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Contrast Media
  • Echinococcosis
  • Echinococcosis, Hepatic / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Iohexol / analogs & derivatives
  • Male
  • Middle Aged
  • Phospholipids
  • Positron-Emission Tomography / methods*
  • Prospective Studies
  • Radiopharmaceuticals
  • Sulfur Hexafluoride
  • Tomography, Spiral Computed / methods*
  • Ultrasonography

Substances

  • Contrast Media
  • Phospholipids
  • Radiopharmaceuticals
  • contrast agent BR1
  • Fluorodeoxyglucose F18
  • Iohexol
  • iopromide
  • Sulfur Hexafluoride

Supplementary concepts

  • Alveolar echinococcosis